Principe et al. found p-ERK1/2 is necessary for TGFβ-induced epithelial–mesenchymal transition (EMT) in pancreatic cancer cells (PCCs), and found inhibition of p-ERK1/2 to both reduce CDK2 levels and prevent EMT [16]. Here, MAPK3 is linked to pancreatic neoplasm.